Company news
Sino Medical Sciences Technology Inc. news in 2026
Sino Medical Sciences Technology Inc.'s news releases, calls and decks from 2026, newest first.
(688108)"Sino Medical Sciences Technology Inc."Announcement on Voluntary Disclosure of Obtaining Overseas Registration Certificate for the Company's Product
October 9, 2026
Announcement on Voluntary Disclosure of Domestic Medical Device Registration Certificates Obtained for Products of a Subsidiary
September 14, 2026
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the SSE STAR Market Medical Device and Medical Equipment Industry
September 9, 2026
Announcement on Voluntary Disclosure of Obtaining a Medical Device Registration Certificate of the People's Republic of China for Subsidiary's Product
September 1, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
August 26, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 24, 2026
Announcement on Voluntary Disclosure of a Subsidiary's Products Obtaining Registration Approval Overseas
August 14, 2026
Announcement on the Subsidiary's Self-Expanding Intracranial Drug-Coated Stent System Obtaining EU MDR Certification
August 9, 2026
Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
July 24, 2026
Voluntary Disclosure Announcement on the Overseas Registration Certificate Obtained for the Company's Product
July 10, 2026
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2026
June 26, 2026
Announcement on Resolutions of the 14th Special Meeting of Independent Directors of the 3rd Board of Directors
June 10, 2026
Announcement on Voluntary Disclosure of Obtaining Registration Certificate for the Company's Products Overseas
June 5, 2026
Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products
May 20, 2026
Announcement on Resolutions of the 17th Meeting of the 3rd Board of Directors
May 15, 2026
Announcement on Implementation Result of Shares Repurchase and Share Changes
May 13, 2026
Announcement on Convening the Q1 2026 Performance Briefing
May 8, 2026
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
May 6, 2026
Report for Q1 2026
April 28, 2026
Notice on Convening the 4th Extraordinary General Meeting in 2026
April 20, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
April 17, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 16, 2026
Announcement on Progress in Repurchasing Shares
April 7, 2026
Notice on the 3rd Extraordinary General Meeting in 2026
March 30, 2026
Announcement on Remuneration Plan for Directors, Supervisors and Senior Management Members in 2025
March 25, 2026
Announcement on Convening the 2025 Annual Performance Briefing
March 20, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
March 13, 2026
Announcement on Shareholding of Top Ten Shareholders and Top Ten Unrestricted Shareholders Before the Record Date of the Shareholders’ Meeting Regarding the Share Repurchase Matter
March 9, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
March 2, 2026
Announcement on Resolutions of the 12th Meeting of the 3rd Board of Directors
February 25, 2026
Announcement on Subsidiary's Product Obtaining EU CE MDR Certification
February 24, 2026
Announcement on Resolutions of the 11th Meeting of the 3rd Board of Directors
February 12, 2026
Announcement on the Company’s Coronary Products Obtaining the Domestic Device Registration Certification
February 4, 2026
Announcement on Expected Increase in Performance for 2025
January 30, 2026
Announcement on Resolutions of the 10th Meeting of the 3rd Board of Directors
January 20, 2026
Announcement on the 2nd Vesting Result in the 3rd Vesting Period of the Initial Grant Part of the Company's 2022 Restricted Stock Incentive Plan and the Listing and Circulation of the Shares
January 19, 2026